711404--12/17/2010--COOPER_COMPANIES_INC

related topics
{product, liability, claim}
{product, market, service}
{operation, international, foreign}
{regulation, government, change}
{cost, regulation, environmental}
{property, intellectual, protect}
{debt, indebtedness, cash}
{condition, economic, financial}
{customer, product, revenue}
{system, service, information}
{tax, income, asset}
{personnel, key, retain}
{provision, law, control}
{competitive, industry, competition}
{acquisition, growth, future}
{cost, operation, labor}
{regulation, change, law}
{product, candidate, development}
Risks Relating to Our Business We operate in the highly competitive healthcare industry and there can be no assurance that we will be able to compete successfully. Acquisitions that we have made and may make in the future involve numerous risks. Product innovations are important in the industry in which we operate, and we face the risk of product obsolescence. If our products are not accepted by the market, we will not be able to sustain or expand our business. New medical and technological developments may reduce the need for our products. Our substantial and expanding international operations are subject to uncertainties which could affect our operating results. Current market conditions and recessionary pressures in one or more of our markets could impact our ability to grow our business. We face risks associated with disruption of manufacturing and distribution operations and failure to develop new manufacturing processes that could adversely affect our profitability or competitive position. If our manufacturing operations fail to comply with applicable regulations, our manufacturing could be delayed or disrupted, and our product sales and profitability could suffer. We rely on independent suppliers for raw materials and we could experience inventory shortages if we were required to use an alternative supplier on short notice. If we fail to protect our intellectual property adequately, our business could suffer. Our products or processes could be subject to claims of infringement of the intellectual property of others. We could experience losses from product liability claims, including such claims and other losses resulting from sales of counterfeit and other infringing products. We face risks related to environmental matters. Our indebtedness could adversely affect our financial health and prevent us from fulfilling our debt obligations. We are vulnerable to interest rate risk with respect to our debt. Exchange rate fluctuations and our foreign currency hedges could adversely affect our financial results. Increases in our effective tax rates or adverse outcomes resulting from examination of income tax returns could adversely affect our results. We operate globally and changes in tax laws could adversely affect our results. We manage our businesses utilizing complex computer systems that are regularly maintained and upgraded, an interruption to these systems could disrupt our business or force us to expend excessive costs. If we do not retain our key personnel and attract and retain other highly skilled employees, our business could suffer. Provisions of our governing documents and Delaware law, and our rights plan, may have anti-takeover effects. Risks Relating to Government Regulation of Manufacture and Sale of Our Products Our failure to comply with regulatory requirements or to receive regulatory clearance or approval for our products or operations could adversely affect our business. Development and marketing of our products are subject to strict governmental regulation by foreign regulatory agencies, and failure to receive, or delay in receiving, foreign qualifications could have a material adverse effect on our business. Our products are subject to reporting requirements and recalls, even after receiving regulatory clearance or approval, which could harm our reputation, business and financial results. Changes in legislation and government regulation of the healthcare industry as well as third-party payors efforts to control the costs of healthcare could materially adversely affect our business. The costs of complying with the requirements of federal laws pertaining to the privacy and security of health information and the potential liability associated with failure to do so could materially adversely affect our business and results of operations. Federal and state laws pertaining to healthcare fraud and abuse could materially adversely affect our business, financial condition and results of operations.

Full 10-K form ▸

related documents
711404--12/21/2009--COOPER_COMPANIES_INC
711404--1/17/2006--COOPER_COMPANIES_INC
711404--12/26/2006--COOPER_COMPANIES_INC
711404--12/19/2008--COOPER_COMPANIES_INC
319240--3/6/2009--IRIS_INTERNATIONAL_INC
319240--3/16/2010--IRIS_INTERNATIONAL_INC
319240--3/14/2008--IRIS_INTERNATIONAL_INC
884909--3/23/2007--HOME_DIAGNOSTICS_INC
1068874--10/12/2006--IMPLANT_SCIENCES_CORP
884909--3/12/2009--HOME_DIAGNOSTICS_INC
749660--3/31/2006--ICAD_INC
949876--1/29/2008--NORTH_AMERICAN_SCIENTIFIC_INC
793279--9/13/2007--CANDELA_CORP_/DE/
793279--9/11/2008--CANDELA_CORP_/DE/
1100441--3/13/2007--REGENERATION_TECHNOLOGIES_INC
1100441--3/16/2006--REGENERATION_TECHNOLOGIES_INC
793279--9/13/2006--CANDELA_CORP_/DE/
892025--12/28/2007--MARTEK_BIOSCIENCES_CORP
884909--3/17/2008--HOME_DIAGNOSTICS_INC
793279--10/1/2009--CANDELA_CORP_/DE/
776008--3/16/2009--STAR_SCIENTIFIC_INC
1100441--2/27/2008--REGENERATION_TECHNOLOGIES_INC
836429--10/28/2009--SYNERGETICS_USA_INC
896778--3/13/2009--CONCEPTUS_INC
203077--2/27/2009--ST_JUDE_MEDICAL_INC
203077--2/28/2007--ST_JUDE_MEDICAL_INC
203077--2/27/2008--ST_JUDE_MEDICAL_INC
850693--3/6/2006--ALLERGAN_INC
1050007--11/23/2010--NUTRACEUTICAL_INTERNATIONAL_CORP
885725--2/26/2010--BOSTON_SCIENTIFIC_CORP